Original Research
Karen E Wickersham, PhD, RN, Kendall Powell, BS, Irene Guterman, MS, RN, CNL, CYT, Catherine O'Malley, MS, RN, Eun-Shim Nahm, PhD, RN, FAAN
The authors evaluate patients’ use of the Internet and patient portals in an outpatient cancer clinic.
The authors report on the use of technology to reduce the administrative burden of tumor boards while improving the quality of care delivered.
Joyce Schaffer, MSN, RN, AOCNS, Susan G. Häag, PhD, MS, Erkut H. Borazanci, MD, David D. Von Hoff, MD
Virtual navigation may be a viable solution to reduce barriers to cancer care and increase patient outcomes, despite geographical location.
Kanako Kashima, MPH, Serena Phillips, RN, MPH, DrPH, Allison C. Harvey, MPH, Aubrey Villalobos, MPH, MEd, DrPH(c), Mandi Pratt-Chapman, MA, PhD, HON-OPN-CG
The authors discuss the efficacy of “The Fundamentals” – a competency-based online Oncology Patient Navigator Training designed by The George Washington University Cancer Center.
The authors explore how minorities affected by prostate cancer can become more informed and active in the decision-making process.
Caitlin Mason, PhD, Jennifer Haase Morris, MBA, Marlee Fisher, MPH, Patti Migliore Santiago, MAOM, Peggy Hannon, PhD, MPH
The authors discuss incorporating the “voice of the survivor” into the delivery of survivorship care planning to better meet the needs of cancer survivors.
Margaret L. Longacre, PhD, Melissa F. Miller, PhD, MPH, Mitch Golant, PhD, Joanne S. Buzaglo, PhD, Alexandra K. Zaleta, PhD
The authors present the results from their study of caregivers’ involvement in treatment decision-making and their need for help in making care decisions as well as communicating with the patient and healthcare team.
The authors present their findings from a study testing the effects of an early intervention by the Breast Cancer Navigator on distress.
Studies indicate that a high fear of cancer recurrence may be correlated with posttraumatic stress disorder in long-term survivors. A better understanding of this fear in cancer survivors can help clinicians manage this problem effectively.
This report evaluates the quality of that evidence and provides a plain language review of the statistics regarding the efficacy of High-Potency Polymerized Cross-linked Sucralfate as well as the inherent limitation of some guideline-supported therapies.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512